Rho Selects Medidata’s Industry-Leading Decentralized Clinical Trial (DCT) Capabilities for Patient-Focused Approach to New Drug Development
NEW YORK & DURHAM, N.C.–(BUSINESS WIRE)–Medidata, a Dassault Systèmes company, today announced that Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is using Medidata to standardize its clinical trial platform for building out its decentralized clinical trial (DCT) technology offerings. This will enable Rho to provide rapid […]

